| Comparative effectiveness of proton vs photon therapy as part of concurrent chemoradiotherapy for locally advanced cancer BC Baumann, N Mitra, JG Harton, Y Xiao, AP Wojcieszynski, PE Gabriel, ... JAMA oncology 6 (2), 237-246, 2020 | 156 | 2020 |
| Effectiveness of first-line immune checkpoint blockade versus carboplatin-based chemotherapy for metastatic urothelial cancer E Feld, J Harton, NJ Meropol, BJS Adamson, A Cohen, RB Parikh, ... European urology 76 (4), 524-532, 2019 | 46 | 2019 |
| Frequency of radiation-induced malignancies post-adjuvant radiotherapy for breast cancer in patients with Li-Fraumeni syndrome AN Le, J Harton, H Desai, J Powers, K Zelley, AR Bradbury, ... Breast cancer research and treatment 181, 181-188, 2020 | 45 | 2020 |
| A Bayesian latent class approach for EHR‐based phenotyping RA Hubbard, J Huang, J Harton, A Oganisian, G Choi, L Utidjian, I Eneli, ... Statistics in Medicine 38 (1), 74-87, 2019 | 31 | 2019 |
| A mixed methods study examining teamwork shared mental models of interprofessional teams during hospital discharge K Manges, PS Groves, A Farag, R Peterson, J Harton, SR Greysen BMJ quality & safety 29 (6), 499-508, 2020 | 28 | 2020 |
| Management of muscle-invasive bladder cancer during a pandemic: Impact of treatment delay on survival outcomes for patients treated with definitive concurrent chemoradiotherapy BW Fischer-Valuck, JM Michalski, JG Harton, A Birtle, JP Christodouleas, ... Clinical Genitourinary Cancer 19 (1), 41-46. e1, 2021 | 8 | 2021 |
| Informative presence bias in analyses of electronic health records-derived data: a cautionary note J Harton, N Mitra, RA Hubbard Journal of the American Medical Informatics Association 29 (7), 1191-1199, 2022 | 7 | 2022 |
| Comparative effectiveness of proton therapy versus photon therapy as part of concurrent chemoradiotherapy for locally advanced cancer. BC Baumann, N Mitra, J Harton, Y Xiao, A Wojcieszynski, PE Gabriel, ... Journal of Clinical Oncology 37 (15_suppl), 6521-6521, 2019 | 6 | 2019 |
| Combining real-world and randomized control trial data using data-adaptive weighting via the on-trial score J Harton, B Segal, R Mamtani, N Mitra, RA Hubbard Statistics in Biopharmaceutical Research 15 (2), 408-420, 2023 | 5 | 2023 |
| Bias reduction methods for propensity scores estimated from error-prone EHR-derived covariates J Harton, R Mamtani, N Mitra, RA Hubbard Health Services and Outcomes Research Methodology 21, 169-187, 2021 | 4 | 2021 |
| Accounting for differential error in time-to-event analyses using imperfect electronic health record-derived endpoints RA Hubbard, J Harton, W Zhu, L Wang, J Chubak New Advances in Statistics and Data Science, 239-255, 2017 | 2 | 2017 |
| Acute toxicity in patients treated with concurrent chemoradiotherapy with proton versus intensity‐modulated radiation therapy for nonmetastatic head and neck cancers KN Kim, J Harton, N Mitra, JN Lukens, A Lin, I Amaniera, A Doucette, ... Head & Neck 44 (11), 2386-2394, 2022 | 1 | 2022 |
| Radiation dose is associated with improved local control for large, but not small, hepatocellular carcinomas U Amit, JJ Mohiuddin, AP Wojcieszynski, J Harton, G Williams, ... Radiation Oncology 18 (1), 133, 2023 | | 2023 |
| Treatment patterns and unmet need for patients with advanced non-small cell lung cancer and poor performance status: A real-world evidence study. SV Liu, J Sussell, D Boudreau, R Schuldt, J Harton, I Bara, A Pregenzer, ... Journal of Clinical Oncology 41 (16_suppl), 9077-9077, 2023 | | 2023 |
| Methods for Comparative Effectiveness Research with Real World Data JG Harton University of Pennsylvania, 2022 | | 2022 |
| Acute Toxicity in Patients Treated With Proton vs. Photon Chemoradiotherapy for Locally Advanced Head and Neck Cancer K Kim, A Doucette, I Amaniera, BC Baumann, J Harton, PE Gabriel, ... International journal of radiation oncology, biology, physics 111 (3), e371-e372, 2021 | | 2021 |
| Comparative effectiveness of proton versus photon chemoradiotherapy for patients with private insurance. BC Baumann, N Mitra, J Harton, Y Xiao, A Wojcieszynski, PE Gabriel, ... Journal of Clinical Oncology 38 (15_suppl), 7049-7049, 2020 | | 2020 |
| Carboplatin-based chemotherapy (C) versus immunotherapy (IO) in metastatic urothelial carcinoma (mUC). E Feld, J Harton, NJ Meropol, BJS Adamson, RB Parikh, MD Galsky, ... Journal of Clinical Oncology 37 (15_suppl), e16003-e16003, 2019 | | 2019 |
| A Comparative Analysis of EHR Phenotyping Algorithms for Pediatric T2dm JG Harton University of Pennsylvania, 2018 | | 2018 |
Nandita MitraProfessor of Biostatistics, University of PennsylvaniaVerified email at upenn.edu
